Zeller International | zeller

from seed to patient

Swiss expertise in phyto-pharmaceuticals since 1864

We develop innovative phyto-pharmaceuticals for selected indication areas to improve patients’ health and quality of life. The efficacy, safety and tolerability of our medicines have been proven in numerous pre-clinical and clinical studies performed by Zeller and published in peer-reviewed journals worldwide.

News

Successful participation at EMAS Congress & 2nd Zeller International Marketing Meeting

Sleep Matters – Not only for your own health, but for society as a whole

Zeller attends Vitafoods Europe

Zeller International Portfolio

We offer phyto-pharmaceuticals in the therapeutic areas of women’s health, the central nervous system and allergy.

Alluna® – Ze 91019

Alluna^® – Ze 91019

For the treatment of sleep disorders.

Remotiv® – Ze 117

Remotiv^® – Ze 117

Treatment of mild to moderate depressive episodes.

Prefemin® – Ze 440

Prefemin^® – Ze 440

Treatment of premenstrual syndrome (PMS) and menstrual cycle disorders.

Cimidona® – Ze 450

Cimidona^® – Ze 450

Treatment of menopausal disorders.

Antilerg® – Ze 339

Antilerg^® – Ze 339

Treatment of allergic rhinitis (hay-fever).

Seed to Patient

Our commitment to the full control of the value chain allows us to guarantee consistency of the processes resulting in high-quality, safe and effective phyto-pharmaceuticals.

Evidence-based Phyto-Therapy

Our phyto-pharmaceuticals have proven efﬁcacy, tolerability and safety in numerous clinical trials performed by Zeller and published in peer-reviewed journals.

About Zeller

We are a leading phyto-pharmaceutical company in Switzerland and have a global network of partners. We are continuously looking for new in- and out-licensing opportunities in selected regions.

© 2019 Max Zeller Söhne AG
Imprint
Privacy Policy